Evidence map›Paper›PMID 34714411›Full record

ArticleJournal of cancer research and clinical oncology2022

Health-related quality of life in children with chronic myeloid leukemia in the chronic phase.

Fangyuan Zheng, Xuelin Dou, Liqiang Zhang, Jie Jin, Yanli Zhang, Bingcheng Liu, Li Meng, Xiaofan Zhu, Zesheng Lu, Yueping Jia and 11 more

Open access · greenAbstract read
In one paragraph

Article in Journal of cancer research and clinical oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Patient-reported toxicity symptoms during tyrosine kinase inhibitor treatment in chronic myeloid leukemia: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 1 country.

Fangyuan Zheng *Department of Pediatrics, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.
Xuelin Dou *Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No. 11 Xizhimen South Street, Beijing, 100044, China.
Liqiang ZhangHematology and Oncology Center, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, China.
Jie JinDepartment of Hematology, Zhejiang University First Affiliated Hospital, Zhejiang, China.
Yanli ZhangDepartment of Hematology, Henan Cancer Hospital, Henan, China.
Bingcheng LiuChinese Academy of Medical Sciences and Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, Tianjin, China.
Li MengDepartment of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Hubei, China.
Xiaofan ZhuChinese Academy of Medical Sciences and Peking Union Medical College, Institute of Hematology and Blood Diseases Hospital, Tianjin, China.
Zesheng LuGuangdong Provincial People's Hospital, Guangdong Provincial Geriatrics Institute Guangzhou, Guangdong, China.
Yueping JiaDepartment of Pediatrics, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.
Huilan LiuDepartment of Hematology, The First Affiliated Hospital of University of Science and Technology of China: Anhui Provincial Hospital, Anhui, China.
Hai LinDepartment of Hematology and Oncology, Jilin University First Hospital, Jilin, China.
Li ZhouShanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai Institute of Hematology, Shanghai, China.
Xielan ZhaoDepartment of Hematology, Xiangya Hospital Central South University, Hunan, China.
Wei YangDepartment of Hematology, Shengjing Hospital of China Medical University, Liaoning, China.
Hui SunDepartment of Hematology, Zhengzhou University First Affiliated Hospital, Henan, China.
Sixuan QianDepartment of Hematology, Nanjing Medical University Affiliated Nanjing Hospital: Nanjing First Hospital, Jiangsu, China.
Hongxia MaDepartment of Hematology, The Third People's Hospital of Zhengzhou, Suzhou, Henan, China.
Runhui WuHematology and Oncology Center, Beijing Children's Hospital Affiliated to Capital Medical University, Beijing, China.
Leping ZhangDepartment of Pediatrics, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China. zhangleping@pkuph.edu.cn.
Qian JiangBeijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, No. 11 Xizhimen South Street, Beijing, 100044, China. jiangqian@medmail.com.cn.ORCID http://orcid.org/0000-0001-7131-0522
Peking University · CNCapital Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNCentral South University · CNChina Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CNFirst Affiliated Hospital Zhejiang University · CNGuangdong Provincial People's Hospital · CNHenan Cancer Hospital · CNJilin University · CNNanjing Medical University · CNShanghai Jiao Tong University · CNThird Affiliated Hospital of Zhengzhou University · CNTongji Hospital · CNUniversity of Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to explore the health-related quality of life (HRQoL) and associated variables in children with chronic myeloid leukemia in the chronic phase (CML-CP) receiving tyrosine kinase inhibitors (TKIs).

methodsA cross-sectional questionnaire was given to children with CML and their parents, who were < 18 years at diagnosis of CML and < 19 years at study. The questionnaire comprised three parts, including demographic information, clinical information, and the Chinese version of Pediatric Quality of Life Inventory

resultsA total of 240 respondents data were analyzed. Multivariate analysis showed that children with symptoms had worse pain (- 10.2; P < 0.001), nausea (- 17.3; P = 0.001), more treatment anxiety (- 7.2; P = 0.005), worse self-assessment appearance (- 7.1; P = 0.001), communication problems (- 6.4; P = 0.001), and worse HRQoL (- 7.0; P < 0.001). Children with mothers having low educational qualifications had worse pain (- 6.0; P = 0.014), more worried about future (- 5.4; P = 0.042), worse cognition problems (- 7.1; P = 0.002), worse communication problems (- 5.5; P = 0.008), and worse HRQoL (- 4.3; P = 0.005). Younger age children at study had more procedural anxiety (2.7; P = 0.001), treatment anxiety (- 1.7; P = 0.014) and cognition problem (3.6; P < 0.001), as well as worse HRQoL (1.8; P = 0.008). However, older age children at diagnosis were more worried about future (- 2.8; P = 0.001), worse self-assessment appearance (- 1.1; P = 0.042) and worse HRQoL (- 1.8; P = 0.007). Other variables significantly associated with worse HRQoL included female gender, rural household registration and their father's low education level. Parents reported more gastrointestinal disorders, were worried about the future and had less concern about appearance than their children.

conclusionsFemale gender, older age at diagnosis, younger age at study, lower mother's education level, and TKI-related symptoms are significantly associated with worse HRQoL in Children with CML. Children and their parents have different priorities in the HRQoL.

Indexed as

Quality of LifeAdolescentChildChild, PreschoolChinaComorbidityCross-Sectional StudiesFemaleHumansLeukemia, Myeloid, Chronic-PhaseMaleSurveys and QuestionnairesChildrenChronic myeloid leukemiaHealth-related quality of life

Identifiers

PMID34714411
PMCPMC11800997
OpenAlexW3176561997

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.